In this week’s edition of “Ask Dr. J”, Dr. Russell Jaffe is asked about the antigen process when it relates to LRA by ELISA/ACT testing.
Effective December 18, 2024, ELISA/ACT Biotechnologies will be temporarily closing for operational research and improvement